The efficacy and tolerance of treatment with combination of cholinesterase inhibitors (ChEls) in patients with Alzheimer's disease over a 12-month period

被引：0
|
作者：
Tsolaki, M. [1 ]
Bosiki, M. [1 ]
Messini, C. H. [1 ]
Kounti, F. [1 ]
Kazis, A. [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Dept Neurol 3, GR-54006 Thessaloniki, Greece
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2005年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [31] Case fatality of patients with stroke over a 12-month period post stroke
    Mudzi, W.
    Stewart, A.
    Musenge, E.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2012, 102 (09): : 765 - 767
  • [32] Electrocardiographic Effects of Cholinesterase Inhibitors in Patients with Alzheimer's Disease
    Colak, Ayse
    Oz, Didem
    NAMIK KEMAL MEDICAL JOURNAL, 2022, 10 (04): : 401 - 405
  • [33] Tolerability of memantine in combination with cholinesterase inhibitors in Alzheimer's disease and vascular dementia
    Hartmann, S
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S84 - S84
  • [34] Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease
    Hogan, David B.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2014, 59 (12): : 618 - 623
  • [35] The cognitive and functional benefits of galantamine: A 12-month study in Alzheimer's disease
    Raskind, M
    Truyen, L
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 460 - 460
  • [36] RESPONSE RATE OF BLACK HYPERTENSIVES TO METHYLDOPA MONOTHERAPY OVER A 12-MONTH TREATMENT PERIOD
    WOOD, M
    HALL, WD
    WOLLAM, GL
    UNGER, DJ
    DOUGLAS, MB
    CLINICAL RESEARCH, 1983, 31 (05): : A845 - A845
  • [37] Gastro-intestinal cancer patients: how they perceive and cope with disease and treatment-related symptoms over a 12-month period
    Brearley, S. G.
    Craven, O.
    Wilson, B.
    Brunton, L.
    Molassiotis, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 234 - 234
  • [38] Cholinesterase inhibitors used in the treatment of Alzheimer's disease the relationship between pharmacological effects and clinical efficacy
    Wilkinson, DG
    Francis, PT
    Schwam, E
    Payne-Parrish, J
    DRUGS & AGING, 2004, 21 (07) : 453 - 478
  • [39] Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease
    Parsons, Chris G.
    Danysz, Wojciech
    Dekundy, Andrzej
    Pulte, Irena
    NEUROTOXICITY RESEARCH, 2013, 24 (03) : 358 - 369
  • [40] Beyond TacrineRecently Developed Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
    Latha K. Unni
    CNS Drugs, 1998, 10 : 447 - 460
12345